Neuland Laboratories balance sheet

As of Mar 2026

Total assets: ₹2,930cr+34.4% on Mar 2025
Shareholders' equity: ₹1,874cr+22.9% on Mar 2025
Total debt: ₹197cr+44.6% on Mar 2025
Cash and investments: ₹76.7cr−68.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	892	674	523	457
	209	44.6	45.9	40.6
	0.0	0.0	19.0	19.3
	279	279	279	279
	5.2	1.7	2.5	1.3
	1.1	3.1	0.0	—
	2.0	1.5	1.3	0.5
	11.9	9.4	8.5	7.7
	13.9	10.9	9.7	8.3
	0.0	11.3	0.0	—
	45.6	15.6	32.2	12.5
	1,447	1,040	911	819
	510	386	350	279
	0.0	108	0.0	0.0
	541	316	374	362
	76.7	132	87.6	45.4
	278	127	29.2	13.7
	4.3	2.2	2.9	7.0
	901	684	493	428
	72.2	69.3	77.4	53.8
	1,483	1,139	921	761
	2,930	2,180	1,833	1,580
Equity
	12.9	12.9	12.9	12.9
	1,862	1,512	1,270	981
	1,874	1,525	1,283	994
	1,874	1,525	1,283	994
Liabilities
	161	90.7	44.9	74.2
	99.7	18.6	9.2	3.8
	261	109	54.1	78.1
	15.9	7.2	7.6	10.3
	69.0	72.8	60.4	58.3
	—	0.0	0.0	0.0
	345	189	122	147
	35.7	45.3	37.6	47.3
	269	252	192	171
	132	87.1	110	68.6
	437	385	340	287
	2.3	2.1	1.6	1.5
	18.2	0.1	0.1	10.4
	253	79.0	86.1	140
	710	466	428	439
	1,056	655	550	586
	2,930	2,180	1,833	1,580
Trade payables — MSME split
	12.6	8.4	—	—
	257	244	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEULANDLAB₹19,970.00

Neuland Laboratories Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB LAURUSLABS NH NATCOPHARM LALPATHLAB SAILIFE COHANCE ASTERDMMcap ₹25,762 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	457.4	522.7	673.7	892.3	892.3
+ Capital Work-in-Progress	40.6	45.9	44.6	209.5	209.5
+ Investment Property	19.3	19.0	0.0	0.0	0.0
+ Goodwill	279.5	279.5	279.5	279.5	279.5
+ Other Intangibles	1.3	2.5	1.7	5.2	5.2
+ Intangibles under Development	—	0.0	3.1	1.1	1.1
+ Non-current Investments	0.5	1.3	1.5	2.0	2.0
+ Other Non-current Financial Assets	7.7	8.5	9.4	11.9	11.9
Non-current Financial Assets	8.3	9.7	10.9	13.9	13.9
+ Deferred Tax Assets	—	0.0	11.3	0.0	0.0
+ Other Non-current Assets	12.5	32.2	15.6	45.6	45.6
Total Non-current Assets	818.9	911.5	1,040.4	1,447.0	1,447.0
Current Assets
+ Inventories	279.2	350.4	385.8	510.3	510.3
+ Current Investments	0.0	0.0	107.7	0.0	0.0
+ Trade Receivables	361.8	373.5	315.7	541.4	541.4
+ Cash & Cash Equivalents	45.4	87.6	131.9	76.7	76.7
+ Other Bank Balances	13.7	29.2	126.9	278.3	278.3
+ Other Current Financial Assets	7.0	2.9	2.2	4.3	4.3
Current Financial Assets	427.9	493.2	684.4	900.7	900.7
+ Other Current Assets	53.8	77.4	69.3	72.2	72.2
Total Current Assets	760.9	921.1	1,139.5	1,483.1	1,483.1
Total Assets	1,579.8	1,832.6	2,179.9	2,930.1	2,930.1
Equity
+ Equity Share Capital	12.9	12.9	12.9	12.9	12.9
+ Other Equity / Reserves	981.2	1,269.8	1,511.9	1,861.6	1,861.6
Equity — Owners of Parent	994.1	1,282.7	1,524.8	1,874.5	1,874.5
Total Equity	994.1	1,282.7	1,524.8	1,874.5	1,874.5
Liabilities
+ Borrowings — Non-current	74.2	44.9	90.7	160.9	160.9
+ Other Non-current Financial Liab	3.8	9.2	18.6	99.7	99.7
Non-current Financial Liabilities	78.1	54.1	109.3	260.6	260.6
+ Provisions — Non-current	10.3	7.6	7.2	15.9	15.9
+ Deferred Tax Liabilities	58.3	60.4	72.8	69.0	69.0
+ Other Non-current Liabilities	0.0	0.0	0.0	—	—
Non-current Liabilities	146.7	122.2	189.4	345.5	345.5
+ Borrowings — Current	47.3	37.6	45.3	35.7	35.7
+ Trade Payables	171.0	192.0	252.2	269.1	269.1
+ Other Current Financial Liab	68.6	110.3	87.1	131.7	131.7
Current Financial Liabilities	286.9	339.8	384.5	436.6	436.6
+ Provisions — Current	1.5	1.6	2.1	2.3	2.3
+ Current Tax Liabilities	10.4	0.1	0.1	18.2	18.2
+ Other Current Liabilities	140.1	86.1	79.0	253.2	253.2
Current Liabilities	439.0	427.7	465.7	710.2	710.2
Total Liabilities	585.7	549.9	655.1	1,055.7	1,055.7
Total Equity & Liabilities	1,579.8	1,832.6	2,179.9	2,930.1	2,930.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	8.4	12.6	12.6
+ Dues to Other Creditors — Current	—	—	243.8	256.5	256.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.